NanoInk appoints James M. Hussey CEO

January 23, 2008 — NanoInk, Inc., creator of dip pen nanolithography (DPN) tools for fabricating MEMS and other nanoscale devices, has announced the appointment of James M. Hussey, 48, as its chief executive officer, as well as a member of its board of directors.

Mr. Hussey joins NanoInk from Ovation Pharmaceuticals, Inc., a leading biopharmaceutical company where he served on the senior management team. Mr. Hussey will be a member of the external Advisory Board of Ovation and remain involved with the company. Mr. Hussey is also an angel investor and has been involved with or founded several early stage biotechnology companies including Silamed Pharmaceuticals, ProCor Pharmaceuticals and Barbeau Pharmaceuticals.

POST A COMMENT

Easily post a comment below using your Linkedin, Twitter, Google or Facebook account. Comments won't automatically be posted to your social media accounts unless you select to share.